Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 84
Optical Disorders Drugs 78
Oncology Drugs 76
Optical 75
Immune Disorders Drugs 68
Cardiovascular Drugs 45
Dermatological Drugs 38
Musculoskeletal Disorders Drugs 38
Biopharmaceuticals 37
Biotechnology 28
Genomics 28
Clinical Trials 27
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 22
Skin Cancer Drugs 21
Infectious Diseases Drugs 19
Allergy and Immunology 17
Central Nervous System Drugs 17
Respiratory Drugs 17
Gastrointestinal Drugs 14
Allergy Drugs 14
Infusions and Injectables 13
Drugs by Therapeutic Area 11
Lung Cancer Drugs 11
Hematological Drugs 11
Leukemia Drugs 9
Diagnostics 8
Dermatology 8
Oncology 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Needles and Syringes 7
Biosimilars and Biosuperiors 6
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Enzymes 5
Company Reports 4
Therapeutic Area 4
Ovarian Cancer Drugs 4
Cardiovascular Devices 4
Transdermal and Transmucosal Drug Delivery 4
Vaccines 4
Liver and Kidney Disorders Drugs 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Pulmonary Medicine 3
Colon Cancer Drugs 3
Proteomics 3
Drug Delivery 3
Laboratory Equipment 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Diabetes Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Pediatrics 2
Cardiology 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

671 Results (Page 20 of 34)
- Relevance
  Sort by

Metastatic Colorectal Cancer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
February 2024
88 Pages
Global

From

€3500EUR$4,120USD£3,106GBP

Facial Erythema Treatment Market 2024-2028

 Report
November 2024
156 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Dermatitis Market Report 2025

 Report
April 2025
175 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Atopic Dermatitis Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Viral Vector Collaboration and Licensing Deals 2016-2024

 Report
November 2024
250 Pages
Global

From

€3636EUR$3,995USD£3,117GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Eczema Therapeutics Market 2024-2028

 Report
April 2024
172 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Chronic Lymphocytic Leukemia Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (GRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-in), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) - Global Forecast to 2029

 Report
November 2024
498 Pages
Global

From

€4505EUR$4,950USD£3,862GBP

Human Papillomavirus 16-positive (HPV16+) Cancers - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7235EUR$7,950USD£6,203GBP

Allergic Rhinitis Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Oncologists Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Anaphylaxis Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

House Dust Mite Allergy Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Acute Coronary Syndrome Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions

 Report
March 2025
211 Pages
Global

From

€4232EUR$4,650USD£3,628GBP

Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
September 2022
194 Pages
Global

From

€4368EUR$4,799USD£3,744GBP

Optic Nerve Disorders Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Antiglaucoma Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Lung Cancer Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

 Report
February 2024
93 Pages
Global

From

€3500EUR$4,120USD£3,106GBP

Ophthalmic Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

671 Results (Page 20 of 34)
- 1
- 18
- 19
- 20
- 21
- 22

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.